Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 2:27 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1225–1248 of 1,391 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Study Pill Clear all

Conditions: Major Depressive Disorder
Interventions: Escitalopram, Placebo oral tablet; Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 60 Years to 90 Years
Enrollment: 138 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Post-traumatic Stress Disorder
Interventions: Propranolol Hydrochloride, Placebo; Drug · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 40 Years and older
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Transplant;Failure,Kidney, Transplant; Failure, Liver, Adherence, Medication, Adherence, Patient, Adherence, Treatment
Interventions: mHealth Messaging Intervention Group; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 13 Years to 25 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Menopause, Brain Activity, Cognition
Interventions: Lisdexamfetamine, Placebo; Drug · Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 45 Years to 60 Years · Female only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Epilepsy
Interventions: Lacosamide Tablet, Lasosamide Oral Solution, Placebo Tablet, Placebo Oral Solution; Drug · Other
Lead sponsor: UCB BIOSCIENCES, Inc.; Industry
Eligibility: 4 Years and older
Enrollment: 242 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 27
States / cities: Alabaster, Alabama • Little Rock, Arkansas • Irvine, California + 23 more

Conditions: Diabetes Mellitus
Interventions: Golytely (polyethylene glycol electrolyte lavage solution) and placebo, split dose of Golytely (polyethylene glycol electrolyte lavage solution) + placebo, split dose of Golytely (polyethylene glycol electrolyte lavage solution) and bisacodyl; Drug
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 75 Years
Enrollment: 212 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Hypothyroidism
Interventions: Levothyroxine Pill, Placebo; Drug
Lead sponsor: Spyridoula Maraka; Other
Eligibility: 65 Years and older
Enrollment: 138 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 3
States / cities: Little Rock, Arkansas • Gainesville, Florida • Rochester, Minnesota

Conditions: Breast Cancer
Interventions: Entinostat, Atezolizumab, Placebo; Drug
Lead sponsor: Syndax Pharmaceuticals; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 19
States / cities: Birmingham, Alabama • Bakersfield, California • Fullerton, California + 15 more

Conditions: Alcoholism
Interventions: Prazosin medication, Placebo medication; Drug
Lead sponsor: Seattle Institute for Biomedical and Clinical Research; Other
Eligibility: 18 Years and older
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Type 2 Diabetes
Interventions: Acipimox, Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 30 Years to 60 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Osteoporosis, Osteopenia
Interventions: melatonin, sugar pill; Dietary Supplement
Lead sponsor: Duquesne University; Other
Eligibility: 45 Years to 54 Years · Female only
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Fatigue, Multiple Myeloma
Interventions: armodafinil, Placebo; Drug
Lead sponsor: Oncotherapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 3
States / cities: Anaheim, California • Newport Beach, California • West Hollywood, California

Conditions: Plaque Psoriasis
Interventions: Prurisol, Placebo; Drug
Lead sponsor: Cellceutix Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 9
States / cities: Huntsville, Alabama • Encino, California • Coral Gables, Florida + 5 more

Conditions: Hypochondriasis
Interventions: Fluoxetine, Cognitive Behavioral Therapy (CBT), Supportive Therapy, Placebo; Drug · Behavioral · Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years and older
Enrollment: 195 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 2
States / cities: Boston, Massachusetts • New York, New York

Conditions: Injury, Inflammation
Interventions: dicreatinol sulfate, placebo sugar pill; Dietary Supplement · Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 25 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Amyotrophic Lateral Sclerosis, Frontal Temporal Dementia
Interventions: Memantine, Placebo (for Memantine); Drug
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years to 85 Years
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 13
States / cities: Phoenix, Arizona • Irvine, California • Jacksonville, Florida + 10 more

Conditions: Multiple Sclerosis
Interventions: Arbaclofen placarbil 15 mg BID, Placebo, Arbaclofen placarbil 30 mg BID, Arbaclofen placarbil 45 mg BID; Drug
Lead sponsor: XenoPort, Inc.; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 228 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 28
States / cities: Phoenix, Arizona • Tucson, Arizona • Berkeley, California + 25 more

Conditions: Nephrectomy
Interventions: Acetaminophen, Placebos, Placebo Oral Tablet; Drug
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years to 89 Years
Enrollment: 214 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Osteoporosis
Interventions: Alendronate; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 5 Years to 15 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Cognitive Impairment, RRSO
Interventions: Lisdexamfetamine, Placebo oral capsule; Drug
Lead sponsor: University of Pennsylvania; Other
Eligibility: 35 Years to 58 Years · Female only
Enrollment: 69 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Pregnancy Preterm, Pregnancy Prom, PROM, Preterm (Pregnancy), PROM (Pregnancy), Premat Rupture Membranes Preterm Unspec to Length of Time Between Rupture/Labor, Premature Birth
Interventions: Azithromycin Pill, Amoxicillin Pill; Drug
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 3
States / cities: Cleveland, Ohio

Conditions: Diabetes, Breast Cancer
Interventions: Integrated Intervention for Breast Cancer Survivors with Diabetes, Attention Control; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 55 Years and older · Female only
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 3
States / cities: Chicago, Illinois • New Hyde Park, New York • New York, New York

Conditions: Post-Traumatic Stress Disorder
Interventions: Carvedilol, Placebo; Drug
Lead sponsor: Columbia Northwest Pharmaceuticals; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 3
States / cities: San Diego, California • Lake Charles, Louisiana • Bellevue, Washington

Conditions: Breast Neoplasms
Interventions: Plavix, Aspirin; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: St Louis, Missouri

Search by objective public record fields.

Mechanisms of Antidepressant Non-Response in Late-Life Depression

Perioperative Propranolol in Patients With Post Traumatic Stress Disorder (PTSD)

Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant

LDX and Functional Magnetic Resonance Imaging (fMRI in Menopausal Women

A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications

Study of Efficacy and Tolerability of Various Bowel Preps in Diabetic Patients

Discontinuation of Low-Dose Levothyroxine in Older Adults With Subclinical Hypothyroidism

Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead In

Study of the Medication Prazosin for Alcohol Dependence

Evaluating the Effects of a Study Medication on Exercise Function in Type 2 Diabetes

Melatonin Osteoporosis Prevention Study

A Study of the Effectiveness of Armodafinil to Treat Cancer-Related Fatigue in Patients With Multiple Myeloma

Efficacy and Safety of Prurisol Administered Orally for Active Mild to Moderate Chronic Plaque Psoriasis

Treatment of Hypochondriasis With CBT and/or SSRI

Nutritional Supplement, Eccentric Exercise and Recovery

Therapy in Amyotrophic Lateral Sclerosis (TAME)

Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis

Efficacy of IV Acetaminophen Versus Oral Acetaminophen

Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis

IMProving Executive Function Study

Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age

Integrated Intervention for Breast Cancer Survivors With Diabetes

Carvedilol Versus Placebo for Treatment in Post Traumatic Stress Disorder (PTSD)

A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients